Caris Life Sciences
$18.18
27
+$0.21+1.17% Monday 19:59
Statistics
Day High
18.62
Day Low
17.93
52W High
42.5
52W Low
14.19
Volume
1,573,210
Avg. Volume
-
Mkt Cap
5.13B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Sep 21
$0.30
Jun 21
$0.30
Mar 21
$0.30
Dec 20
$0.25
Sep 20
$0.25
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
18AugExpected
Expected EPS
0.015459
Actual EPS
N/A
Financials
-68.38%Profit Margin
Unprofitable824.52MRevenue
-563.78MNet Income
Analyst Ratings
27.38Average Price Target
The highest estimate is 32.00.
From 9 ratings within the last 6 months. This is not an investment recommendation.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy 67%
Hold 33%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CAI. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Show more...
CEO
Dr. David Dean Halbert M.D.
Employees
1769
Country
United States
ISIN
US1421521071
Listings
0 Comments
Share your thoughts
FAQ
What is Caris Life Sciences stock price today?▼
The current price of CAI is $18.18 USD — it has increased by +1.17% in the past 24 hours. Watch Caris Life Sciences stock price performance more closely on the chart.
What is Caris Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Caris Life Sciences stocks are traded under the ticker CAI.
What is Caris Life Sciences market cap?▼
Today Caris Life Sciences has the market capitalization of 5.13B
When is the next Caris Life Sciences earnings date?▼
Caris Life Sciences is going to release the next earnings report on August 18, 2026.
What were Caris Life Sciences earnings last quarter?▼
CAI earnings for the last quarter are 0 USD per share, whereas the estimation was -0.02 USD resulting in a +100% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Caris Life Sciences revenue for the last year?▼
Caris Life Sciences revenue for the last year amounts to 824.52M USD.
What is Caris Life Sciences net income for the last year?▼
CAI net income for the last year is -563.78M USD.
Does Caris Life Sciences pay dividends?▼
Yes, CAI dividends are paid quarterly. The last dividend per share was 0.3 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Caris Life Sciences have?▼
As of June 16, 2026, the company has 1,769 employees.
In which sector is Caris Life Sciences located?▼
Caris Life Sciences operates in the Health & Wellness sector.
When did Caris Life Sciences complete a stock split?▼
Caris Life Sciences has not had any recent stock splits.
Where is Caris Life Sciences headquartered?▼
Caris Life Sciences is headquartered in Irving, United States.